These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 31532096)

  • 1. Comparative LC-MS/MS and HPLC-UV Analyses of Meropenem and Piperacillin in Critically Ill Patients.
    Paal M; Heilmann M; Koch S; Bertsch T; Steinmann J; Höhl R; Liebchen U; Schuster C; Kleine FM; Vogeser M
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC-MS/MS method.
    Paal M; Zoller M; Schuster C; Vogeser M; Schütze G
    J Pharm Biomed Anal; 2018 Apr; 152():102-110. PubMed ID: 29414000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preanalytical Stability of Piperacillin, Tazobactam, Meropenem, and Ceftazidime in Plasma and Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry.
    Mortensen JS; Jensen BP; Zhang M; Doogue M
    Ther Drug Monit; 2019 Aug; 41(4):538-543. PubMed ID: 31306394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Routine Therapeutic Drug Monitoring of Mycophenolic Acid in human Plasma with HPLC-UV and Isotope Dilution LC-MS/MS.
    Paal M; Habler K; Northoff B; Vogeser M
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation.
    D'Cunha R; Bach T; Young BA; Li P; Nalbant D; Zhang J; Winokur P; An G
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
    Esteve-Pitarch E; Padullés-Zamora A; Maisterra-Santos K; Colom-Codina H; Cobo-Sacristán S
    Farm Hosp; 2019 Sep; 43(5):151-157. PubMed ID: 31469627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new HPLC-MS/MS analytical method for quantification of tazobactam, piperacillin, and meropenem in human plasma.
    Krnáč D; Reiffová K; Rolinski B
    J Sep Sci; 2021 Jul; 44(14):2744-2753. PubMed ID: 33988308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
    Decosterd LA; Mercier T; Ternon B; Cruchon S; Guignard N; Lahrichi S; Pesse B; Rochat B; Burger R; Lamoth F; Pagani JL; Eggimann P; Csajka C; Choong E; Buclin T; Widmer N; André P; Marchetti O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122160. PubMed ID: 32891946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of nine β-lactam antibiotics in human plasma by an ultrafast hydrophilic-interaction chromatography-tandem mass spectrometry.
    Abdulla A; Bahmany S; Wijma RA; van der Nagel BCH; Koch BCP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():138-143. PubMed ID: 28618388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.
    Schoenenberger-Arnaiz JA; Ahmad-Diaz F; Miralbes-Torner M; Aragones-Eroles A; Cano-Marron M; Palomar-Martinez M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e30-e35. PubMed ID: 32296502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
    Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
    J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of β-lactam antibiotic concentration in human plasma.
    Rigo-Bonnin R; Ribera A; Arbiol-Roca A; Cobo-Sacristán S; Padullés A; Murillo Ò; Shaw E; Granada R; Pérez-Fernández XL; Tubau F; Alía P
    Clin Chim Acta; 2017 May; 468():215-224. PubMed ID: 28288784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and Linezolid in Human Plasma Samples.
    Piestansky J; Cizmarova I; Mikus P; Parrak V; Babiak P; Secnik P; Secnik P; Kovac A
    Ther Drug Monit; 2022 Dec; 44(6):784-790. PubMed ID: 35971670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples.
    Ferrari D; Ripa M; Premaschi S; Banfi G; Castagna A; Locatelli M
    J Pharm Biomed Anal; 2019 May; 169():11-18. PubMed ID: 30826487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients.
    Barco S; Mesini A; Barbagallo L; Maffia A; Tripodi G; Pea F; Saffioti C; Castagnola E; Cangemi G
    J Pharm Biomed Anal; 2020 Jul; 186():113273. PubMed ID: 32251979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
    Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactam antibiotic concentrations in critically ill patients with standard and adjusted dosages: A prospective observational study.
    Areskog Lejbman I; Torisson G; Resman F; Sjövall F
    Acta Anaesthesiol Scand; 2024 Apr; 68(4):530-537. PubMed ID: 38407447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV.
    Pinder N; Brenner T; Swoboda S; Weigand MA; Hoppe-Tichy T
    J Pharm Biomed Anal; 2017 Sep; 143():86-93. PubMed ID: 28578254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry.
    Barco S; Bandettini R; Maffia A; Tripodi G; Castagnola E; Cangemi G
    J Chemother; 2015; 27(6):343-7. PubMed ID: 25178412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients.
    Neugebauer S; Wichmann C; Bremer-Streck S; Hagel S; Kiehntopf M
    Ther Drug Monit; 2019 Feb; 41(1):29-37. PubMed ID: 30320624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.